Systematic Review
Accepted on 28 Nov 2024
Factors affecting posaconazole plasma concentrations: A metaanalysis and systematic review
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1450120
Type at least 3 characters
1,955 articles
Articles
Original Research
Published on 28 Nov 2024
Trajectories of adherence to intravenous biological treatment in patients with inflammatory bowel disease: a longitudinal analysis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1431035
Perspective
Accepted on 27 Nov 2024
Reframing risks in rare diseases: Economics of networks, spillovers, and scale
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1516725
Review
Accepted on 26 Nov 2024
Cutaneous Adverse Events Associated With BRAF and MEK Inhibitors: A Systematic Review and Meta-analysis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1457226
Original Research
Accepted on 26 Nov 2024
Comparison of intravitreal anti-VEGF agents and oral carbonic anhydrase inhibitors in the treatment of cystoid macular edema secondary to retinitis pigmentosa
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1477889
Perspective
Accepted on 26 Nov 2024
Sustainable Integration of Artificial Intelligence and Machine Learning Approaches within the African Infectious Disease Vaccine Research & Development Ecosystem
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1499079
- 138 views
Systematic Review
Published on 26 Nov 2024
Association between various types of corticosteroids and mortality for severe community-acquired pneumonia in adults: a systematic review and network meta-analysis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1479804
- 172 views
Original Research
Published on 26 Nov 2024
Machine learning models for coagulation dysfunction risk in inpatients administered β-lactam antibiotics
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1503713
- 109 views
Original Research
Accepted on 25 Nov 2024
Despite the Pandemic: Upward Trajectories of Medication Adherence and Persistence in Patients with Dyslipidemia
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1488452
Editorial
Published on 25 Nov 2024
Editorial: Recent advances in attempts to improve medication adherence – from basic research to clinical practice, volume II
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1521468
- 257 views
Review
Published on 22 Nov 2024
Expert consensus on the off-label use in China of drugs for rare hematologic diseases (2024 edition)
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1477550
- 230 views
Original Research
Published on 20 Nov 2024
Cost-effectiveness analysis of tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced gastric or gastroesophageal junction adenocarcinoma: perspectives from the United States and China
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1461571
- 240 views
Original Research
Published on 20 Nov 2024
Optimization of initial dosage of quetiapine in schizophrenic patients: effects of fluvoxamine or duloxetine coadministration
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1496043
- 189 views
Original Research
Published on 20 Nov 2024
Machine learning models can predict cancer-associated disseminated intravascular coagulation in critically ill colorectal cancer patients
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1478342
- 209 views
Original Research
Published on 20 Nov 2024
A real-world pharmacovigilance analysis of adverse events associated with irbesartan using the FAERS and JADER databases
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1485190
- 294 views
Original Research
Accepted on 19 Nov 2024
Kidney Outcomes Associated with SGLT2 Inhibitors Compared to Other Glucose-Lowering drugs: A Real-world Study from China
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1468435